Dr. Shadia Grishma

And the last thing I'll add is diabetes disproportionately affects minority populations and those with less socioeconomic means. Imagine if we could improve that without costly medications and prevent it and close some of the complication gaps and the death gaps that we have in the United States.

And the last thing I'll add is diabetes disproportionately affects minority populations and those with less socioeconomic means. Imagine if we could improve that without costly medications and prevent it and close some of the complication gaps and the death gaps that we have in the United States.

And there's all the ways in which... And equity around getting medications.

And there's all the ways in which... And equity around getting medications.

And there's all the ways in which... And equity around getting medications.

accessing expensive medications and accessing expensive technology like CGM. There's all kinds of equity issues. So what if we went to the root cause and just helped people be healthier from day one?

accessing expensive medications and accessing expensive technology like CGM. There's all kinds of equity issues. So what if we went to the root cause and just helped people be healthier from day one?

accessing expensive medications and accessing expensive technology like CGM. There's all kinds of equity issues. So what if we went to the root cause and just helped people be healthier from day one?

Well, I think part of it is that we all sort of have our belief systems that we grow up in and we're mentored in. And even with research, when a trial is negative, it's very unlikely to get published, right? So we sort of perpetuate biases in medicine. And so there's sort of like this bias built into the science. But I think slowly we're going to see that change. And I think

Well, I think part of it is that we all sort of have our belief systems that we grow up in and we're mentored in. And even with research, when a trial is negative, it's very unlikely to get published, right? So we sort of perpetuate biases in medicine. And so there's sort of like this bias built into the science. But I think slowly we're going to see that change. And I think

Well, I think part of it is that we all sort of have our belief systems that we grow up in and we're mentored in. And even with research, when a trial is negative, it's very unlikely to get published, right? So we sort of perpetuate biases in medicine. And so there's sort of like this bias built into the science. But I think slowly we're going to see that change. And I think

now that we're in the age of more data and big data like i think the outcomes speak for themselves and i think what we've just been saying like the what the triple the triple aim uh of better outcomes better patient experience at lower cost that that is going to drive things forward and i think sami's point of saying like the business model is really important and i don't think i would have said this four years ago but after working at virta

now that we're in the age of more data and big data like i think the outcomes speak for themselves and i think what we've just been saying like the what the triple the triple aim uh of better outcomes better patient experience at lower cost that that is going to drive things forward and i think sami's point of saying like the business model is really important and i don't think i would have said this four years ago but after working at virta

now that we're in the age of more data and big data like i think the outcomes speak for themselves and i think what we've just been saying like the what the triple the triple aim uh of better outcomes better patient experience at lower cost that that is going to drive things forward and i think sami's point of saying like the business model is really important and i don't think i would have said this four years ago but after working at virta

Because no, I mean, I practiced in a model where I was in that fee-for-service, even though I was an academic clinician, I was in that fee-for-service model.

Because no, I mean, I practiced in a model where I was in that fee-for-service, even though I was an academic clinician, I was in that fee-for-service model.

Because no, I mean, I practiced in a model where I was in that fee-for-service, even though I was an academic clinician, I was in that fee-for-service model.

And so even if I provided excellent care, I needed to spin my wheels and race through my clinic and try to get everybody through as fast as I could so I could stay on schedule and then do my pajama charts late at night because I don't have time to do any of my documentation, which is excessive, it's burning out clinicians.

And so even if I provided excellent care, I needed to spin my wheels and race through my clinic and try to get everybody through as fast as I could so I could stay on schedule and then do my pajama charts late at night because I don't have time to do any of my documentation, which is excessive, it's burning out clinicians.

And so even if I provided excellent care, I needed to spin my wheels and race through my clinic and try to get everybody through as fast as I could so I could stay on schedule and then do my pajama charts late at night because I don't have time to do any of my documentation, which is excessive, it's burning out clinicians.